9/13/2019 Contest update
Although triskaidekaphobia may have kept some biotech investors on the sidelines Friday, the sector did manage to have a decent week.
At Friday’s close, the Contest median was up 13.17% YTD (vs. up 12.37% a week ago), the Nasdaq Biotech Index (NBI) was up 7.62% YTD (vs. up 5.54% a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 14.17% YTD (vs. up 10.21% a week ago), while the Nasdaq Composite Index (NCI) was up 23.23% YTD (vs. up 22.12% YTD a week ago).
BULBA’s portfolio had a good week, continuing as Contest leader with a 99.12% YTD gain. ANDRE’s portfolio, up 53.67% YTD, and OHMS’ portfolio, up 51.41% YTD, remained in second and third place.
At Friday's close, 29 of the 39 Contest portfolios were still in the green, while 25 were now beating the NBI and 18 were now beating the SPSIBI.
The 167 Contest stock picks have an average YTD gain of 17.59% and, moving back into positive territory, a median YTD gain of 4.17%.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits & mergers, greatly appreciated.)
Enjoy a safe and relaxing penultimate summer weekend biotechies!
Peace & good health,
Bulba
9/13/19
Rank Name Profit/Loss
1 BULBA 99,121
2 ANDRE 53,665
3 OHMS 51,409
4 ARTHUR 45,851
5 DEWO 45,268
6 HOOD 42,774
7 KMASTR 38,341
8 RKRW 32,711
9 LANCE 29,843
10 AJM 29,507
Week's Top 5 Gainers
Symbol 9/6/19 9/13/19 Wk.%chg.
ACAD 23.800 40.450 69.96%
LXRX 1.380 2.340 69.57%
FCSC 1.830 2.920 59.56%
NTEC 0.739 1.150 55.72%
GLYC 3.480 4.620 32.76%
Week's Worst 5 Losers
Symbol 9/6/19 9/13/19 Wk.%chg.
RTTR 1.160 0.324 -72.07%
TOCA 3.160 1.030 -67.41%
ADVM 12.120 5.780 -52.31%
ATRX 0.120 0.080 -33.33%
APLS 32.180 27.000 -16.10%
|
